Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

S&P 500 Makes Strong Start to October as Merck Covid Pill Lifts Sentiment

Published 10/01/2021, 03:58 PM
Updated 10/01/2021, 04:17 PM
© Reuters.

By Yasin Ebrahim

Investing.com – The S&P 500 rose sharply Friday,  as positive results from Merck's Covid-19 pill stoked investor optimism and triggered a sea of green on Wall Street following a sloppy September.

The S&P 500 rose 1.1%, the Dow Jones Industrial Average gained 1.4%, or 482 points, the Nasdaq was up 0.8%.

Merck & Company Inc (NYSE:MRK) reported that its experimental Covid-19 pills cut the risk of death and hospitalization by 50% in a study, sending its share price more than 8% higher.

The positive Covid-19 treatment news stoked investor optimism about the recovery amid an ongoing drag from the impact of the Delta variant.

Cyclical stocks including materials and energy took the lead, with the latter helped by expectations that energy prices will continue to climb to as high as $100 a barrel.

“If all these factors come together, oil prices could spike and lead to a second round of inflationary pressures around the world,” Bank of American said in a note.

Exxon Mobil (NYSE:XOM) was up nearly 4% after raising its forecast on third-quarter earnings, citing higher oil and gas prices. The oil major said higher energy prices could boost earnings by as much as $1.5 billion.

Bets on reopening stocks – those that benefit from easing pandemic restrictions – renewed, with cruise and airlines companies leading the way.

United Airlines Holdings (NASDAQ:UAL), American Airlines Group (NASDAQ:NASDAQ:AAL), Carnival (NYSE:CCL) and Norwegian Cruise (NYSE:NCLH) were sharply higher.

Big tech, which fell victim to rising interest rates recently, found its footing.  

Apple (NASDAQ:AAPL), Facebook (NASDAQ:FB) and Alphabet (NASDAQ:GOOGL), and Microsoft (NASDAQ:MSFT) ended in the green. Amazon.com (NASDAQ:AMZN) closed lower.

On the economic front, the faster pace of inflation shows little sign of abating, but the consumer, which makes up about two-thirds of the economy, continues to spend.

The Federal Reserve's preferred inflation measure, the personal consumption expenditures (PCE) price index excluding food and energy, rose 3.6% in the 12 months through September.

Consumer spending in July rose by 0.8% month-on-month, from a 0.1% decline in the prior month.

“We remain constructive on consumer spending in the coming quarters. Even as the impulse from fiscal stimulus targeted at households fades, labor market  income and a savings cushion should support continued spending,” Morgan Stanley (NYSE:MS) said.

In Washington, meanwhile, House Speaker Nancy Pelosi was forced to delay a planned vote on the $1 trillion bipartisan infrastructure package amid ongoing wrangling within the Democratic caucus.

The House was hoping to pass the bipartisan infrastructure package and the $3.5 trillion reconciliation bill simultaneously, as part of a two-track strategy. But Sen. Joe Manchin said he would support a reconciliation package worth only $1.5 trillion, well short of the proposed $3.5 trillion. 

Looking ahead, investors anticipate another wild week amid several events that could dominate direction in the broader market, including the Federal Reserve's September meeting minutes, the OPEC meeting, and the monthly jobs report to round out the week. 

"Since labor supply issues became apparent this spring, we've been eagerly awaiting September payrolls, expecting them to show a sharp acceleration in the pace of hiring," Jefferies (NYSE:JEF) said in a note.

Latest comments

hello
This is great on October
Is it just me that notices the fact that under Trump we had smaller well funded options for a vaccine, and then when Biden came in surprise, surprise, the Big Pharma companies won out, or is that just me? Weird, and we are having problems and need new options, and SURPRISE!! Its Merck, another Big Pharma Co. Wow
Our president is a senile fool and our economy goes to dumpster. Big part of population are brainwashed fools while ruling elites are mostly crooks. However, the market will go higher. This is the last refuge, use it.
And this is the last effort, from your news update, trying to write something about nothing we know but, BELIEVE US, otherwise all the app will be empty of articles. Thank you.
insurrectionists, anti science + anti maskers + anti vaxers, and now anti pill takers = ...help me out pls
omg what a drama queen u are. how about mostly peaceful protests as hard working Americans lose their business to violent looters. mail in ballots from dead people. i can go on.
so you are saying the market rallied some few points up because there is a news about covid pill wow 🤣🤣 See you next week when you connect this to some other things when it drops
Hi I thank you for allowing me to join this investing.com I will like to know more of this platform and I am hoping that this platform will pay me well.
You can't get half the population to get a shot, you think they'll pop a pill? They can put a bigger tracking device in a pill!
ok so it takes some BS news about some miracle pill?? wow this game is even better than monopoly! can't wait for Monday Asia opening, HK was closed today, how appropriate.... we are in for a wild ride again.
Bro youre right , all of the satan, magic pill from no where, tomorrow…. Satanly they are safer than corona virus vaccines!!.. From take a jab to just swallow pills !!This is evil !!..
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.